Prilozi最新文献 - Book学术

Continuous Peripheral Block as a Pain Treatment for Redressment and Physical Therapy in a 7-Year-Old Child – A Case Report 连续外周阻滞作为7岁儿童疼痛治疗和物理治疗的一例报告

Prilozi Pub Date : 2022-03-01 DOI: 10.2478/prilozi-2022-0011

L. Mikjunovikj-Derebanova, L. Donev, L. Todorović, Vesna Cvetanovska-Naunov, V. Demjanski, Natalija Cokleska-Shuntov, V. Ognjanova

{"title":"Continuous Peripheral Block as a Pain Treatment for Redressment and Physical Therapy in a 7-Year-Old Child – A Case Report","authors":"L. Mikjunovikj-Derebanova, L. Donev, L. Todorović, Vesna Cvetanovska-Naunov, V. Demjanski, Natalija Cokleska-Shuntov, V. Ognjanova","doi":"10.2478/prilozi-2022-0011","DOIUrl":"https://doi.org/10.2478/prilozi-2022-0011","url":null,"abstract":"Abstract Continuous peripheral nerve block, also known as “local anesthetic perineural infusion,” refers to percutaneous placement of a catheter near a peripheral nerve or plexus followed by administration of a local anesthetic through a catheter to provide anesthesia, or analgesia for several days, in some cases even for a month. This report describes the case of a 7 year old boy with left elbow contracture with limited flexion and extension who was admitted to the Clinic of Pediatric Surgery for redressment of the elbow and physical therapy. An ultrasound-guided axillary brachial plexus block was performed, with placement of a non-tunneled perineural catheter. Redressment of the left elbow was performed twice and before each redressment boluses of local anesthetic were applied through the perineural catheter. Physical therapy was performed painlessly with continuous perineural infusion. On the 5th day of catheter placement, the perineural catheter was removed without any prior complications such as hematoma, infection, catheter dislocation or leakage of local anesthetic. Our goal is to minimize the psychological and physical trauma to the patient, no matter how immature the patient is. Continuous regional anesthesia in children is a safe technique in postoperative pain management that facilitates early mobilization due to its sufficient analgesia and better comfort. It can provide in-home treatment, with adequate education for patients and parents, and improve rehabilitation in children.","PeriodicalId":87202,"journal":{"name":"Prilozi","volume":"34 1","pages":"99 - 104"},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77841445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Vaccine-Inducted Thrombotic Thrombocytopenia and Covid-19 Vaccines: Case Series 疫苗诱导的血栓性血小板减少症和Covid-19疫苗:病例系列

Prilozi Pub Date : 2022-03-01 DOI: 10.2478/prilozi-2022-0005

E. Trajkovska, I. Mitevska, M. Bosevski, Collaborators: Elena Grueva Nastevska, Ana Chelikikj, Atanas Gjorgjievski

引用次数: 1

Hypoxic Ischemic Encephalopathy (HIE) in Term and Preterm Infants 足月和早产儿的缺氧缺血性脑病(HIE)

Prilozi Pub Date : 2022-03-01 DOI: 10.2478/prilozi-2022-0013

Sandra Ristovska, O. Stomnaroska, D. Danilovski

{"title":"Hypoxic Ischemic Encephalopathy (HIE) in Term and Preterm Infants","authors":"Sandra Ristovska, O. Stomnaroska, D. Danilovski","doi":"10.2478/prilozi-2022-0013","DOIUrl":"https://doi.org/10.2478/prilozi-2022-0013","url":null,"abstract":"Abstract Hypoxic-ischemic syndrome (HIS) and Hypoxic-ischemic encephalopathy (HIE) are conditions that affect term and premature babies, with different pathophysiology and different brain disorders. HIE appears in 1-6 / 1000 live births and 26/1000 live births in developing countries. 15-20% die in the early neonatal period, while surviving babies have severe neurological impairment, including cerebral palsy, epilepsy, visual and hearing impairment, cognitive impairment, intellectual, behavioural, and social disorders. The hypoxic-ischemic event occurs before, during or after birth. The reasons may be related to the mother, the way of birth, the placenta, and the newborn. The criteria for diagnosis of HIE include a combination of perinatal factors, the need for resuscitation, standard neurological examinations, neurophysiological monitoring, neuroimaging methods and biochemical markers. The most effective treatment for HIE is hypothermia in combination with pharmacological therapy. HIE and HIS are problem that still persist in developing countries due to inadequate obstetric care, neonatal resuscitation, and hypothermia. Current and emerging research for HIE examines new markers for early recognition, treatment, and appropriate neuroprotection of high-risk term and premature infants.","PeriodicalId":87202,"journal":{"name":"Prilozi","volume":"41 1","pages":"77 - 84"},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86672515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Antioxidative Effects of Rosuvastatin in Low-to-Moderate Cardiovascular Risk Subjects 瑞舒伐他汀在中低心血管风险受试者中的抗氧化作用

Prilozi Pub Date : 2022-03-01 DOI: 10.2478/prilozi-2022-0007

Ana Vavlukis, M. Vavlukis, K. Mladenovska, Aleksandar S. Dimovski, Natàlia Muñoz-García, Victoria de Santisteban Villaplana, T. Padró, L. Badimón

{"title":"Antioxidative Effects of Rosuvastatin in Low-to-Moderate Cardiovascular Risk Subjects","authors":"Ana Vavlukis, M. Vavlukis, K. Mladenovska, Aleksandar S. Dimovski, Natàlia Muñoz-García, Victoria de Santisteban Villaplana, T. Padró, L. Badimón","doi":"10.2478/prilozi-2022-0007","DOIUrl":"https://doi.org/10.2478/prilozi-2022-0007","url":null,"abstract":"Abstract Background: Although vast clinical evidence supports the oxidative CVD hypothesis, little is known on the effects of statins on LDL/HDL oxidative functionality. Therefore, the aim of this study was to evaluate the antioxidative effects of rosuvastatin by monitoring the susceptibility of LDL to oxidation and the antioxidative HDL potential in low-to-moderate CV risk subjects. Methods: 40 adult ambulatory patients (aged 53.8±10.9 years, 27 women and 13 men) were included in the study. Data was collected from patients’ records, physical examination, and blood sampling. Subjects were prescribed rosuvastatin at 20mg/day. Traditional risk-factors/indicators, lipid parameters, inflammatory/immune markers, LDL susceptibility to oxidation and HDL antioxidative potential were monitored and statistically analyzed with t-test, Chi-square test, one-way ANOVA, Mann-Whitney, and Kruskal-Wallis tests. Multivariate logistic regression analyses were made. Results were considered significant when p≤0.05. Results: 67% of the patients showed lower susceptibility of LDL to oxidation after rosuvastatin treatment (p=0.03), with no significant effect on baseline LDL oxidation and lag time. All three LDL oxidative indices were seen to be dependent on the subjects’ lipid profile, hemoglobin levels and the IL-1α and IL-8 pro-inflammatory marker levels. 53% of the patients showed higher HDL antioxidative capacity after treatment, but without statistical significance (p=0.07). Increased antioxidative potential of HDL with rosuvastatin treatment was more likely in males (OR=9.350; p=0.010), and subjects achieving lower post-treatment CV relative risk levels (higher CV risk reduction) (OR=0.338; p=0.027). Conclusions: This study suggests the need of a comprehensive approach when investigating oxidative stress and LDL/HDL functions, especially in low-to-moderate CVD risk subjects.","PeriodicalId":87202,"journal":{"name":"Prilozi","volume":"39 1","pages":"65 - 75"},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86172763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Inflammatory Bowel Diseases in Renal Transplantat Recipients: A Case Series and Review of the Literature 肾移植受者的炎症性肠病:病例系列和文献综述

Prilozi Pub Date : 2022-03-01 DOI: 10.2478/prilozi-2022-0006

Jakob Vrus, N. Jukić

{"title":"Inflammatory Bowel Diseases in Renal Transplantat Recipients: A Case Series and Review of the Literature","authors":"Jakob Vrus, N. Jukić","doi":"10.2478/prilozi-2022-0006","DOIUrl":"https://doi.org/10.2478/prilozi-2022-0006","url":null,"abstract":"Abstract Inflammatory bowel diseases are autoimmune disorders affecting the gastrointestinal tract and producing a wide variety of extraintestinal manifestations. Kidneys are a rare target organ of their extraintestinal activity, but if affected, renal function could deteriorate to end-stage kidney disease, which is curable only by organ transplantation. Renal calculi are the most common pathological kidney manifestation in IBD patients, followed by tubulointerstitial nephritis, glomerulonephritis, and other kidney pathologies. The liver is the most commonly transplanted organ in IBD patients (primary sclerosing cholangitis and autoimmune hepatitis), and a scarcity of literature on kidney recipients is present to date regarding the incidence of renal insufficiency, kidney transplantations, post-transplant IBD course and further complications such as graft rejection or infections in this specific group of patients. De novo IBD is a paradoxical entity in the setting of rigorous post-transplant immunosuppression. In this case series, we present three patients who underwent kidney transplantation with a history of an IBD and one patient who developed de novo Crohn’s disease after the deceased donor organ transplant was performed.","PeriodicalId":87202,"journal":{"name":"Prilozi","volume":"11 1","pages":"57 - 63"},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82324430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Author’s Response to Letter to the Editor: Is Opioid-Free General Anesthesia More Superior for Postoperative Pain Versus Opioid General Anesthesia in Laparoscopic Cholecystectomy? 作者对编辑的回复:在腹腔镜胆囊切除术中，无阿片类药物全麻比阿片类药物全麻更能缓解术后疼痛?

Prilozi Pub Date : 2022-03-01 DOI: 10.2478/prilozi-2022-0012

M. Toleska, A. Dimitrovski

引用次数: 0

The Personality Profiles for Contemporary Macedonian Actors 当代马其顿演员的性格特征

Prilozi Pub Date : 2022-03-01 DOI: 10.2478/prilozi-2022-0001

N. Pop-Jordanova

引用次数: 0

Childbirth-Related Psychological Trauma 与分娩有关的心理创伤

Prilozi Pub Date : 2022-03-01 DOI: 10.2478/prilozi-2022-0002

N. Pop-Jordanova

引用次数: 5

Prophylactic Regenerative Peripheral Nerve Interfaces in Elective Lower Limb Amputations 选择性下肢截肢的预防性再生周围神经界面

Prilozi Pub Date : 2022-03-01 DOI: 10.2478/prilozi-2022-0004

S. Pejkova, Bisera Nikolovska, Blagoja Srbov, Sofija Tusheva, Tomislav Jovanoski, Katerina Jovanovska, Gordana Georgieva

{"title":"Prophylactic Regenerative Peripheral Nerve Interfaces in Elective Lower Limb Amputations","authors":"S. Pejkova, Bisera Nikolovska, Blagoja Srbov, Sofija Tusheva, Tomislav Jovanoski, Katerina Jovanovska, Gordana Georgieva","doi":"10.2478/prilozi-2022-0004","DOIUrl":"https://doi.org/10.2478/prilozi-2022-0004","url":null,"abstract":"Abstract Regenerative peripheral nerve interface (RPNI) is a relatively new surgical technique to manage neuromas and phantom pain after limb amputation. This study evaluates prophylactic RPNI efficacy in managing post-amputation pain and neuroma formation in amputees compared with patients in which lower limb amputation was performed without this procedure. We included 28 patients who underwent above the knee amputation (AKA) or below the knee amputation (BKA) for severe soft tissue infection from July 2019 till December 2020. All patients had insulin-dependent diabetes. The patients were divided into two groups, 14 patients with primary RPNI and 14 patients without. We analyzed the demographic data, level of amputation, number of RPNIs, operative time, postoperative complications and functional outcome on the defined follow up period. The mean patient age was 68.6 years (range 49–85), 19 (67.9 %) male and 9 (32.1 %) female patients. In this study 11 (39.3 %) AKA and 17 (60.7 %) BKA were performed. Overall, 37 RPNIs were made. The mean follow-up period was 49 weeks. PROMIS T-score decreased by 15.9 points in favor for the patients with RPNI. The VAS score showed that, in the RPNI group, all 14 patients were without pain compared to the group of patients without RPNI, where the 11 (78.6 %) patients described their pain as severe. Patients with RPNI used prosthesis significantly more (p < 0.005). Data showed significant reduction in pain and high patient satisfaction after amputation with RPNIs. This technique is oriented as to prevent neuroma formation with RPNI surgery, performed at the time of amputation. RPNI surgery did not provoke complications or significant lengthening of operative time and it should be furthermore exploited as a surgical technique.","PeriodicalId":87202,"journal":{"name":"Prilozi","volume":"53 1","pages":"41 - 48"},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73882822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4

The Effects of CNI and Mtori-Based Regimens on Bone Mineral Density After Renal Transplantation CNI和mtori对肾移植术后骨矿物质密度的影响

Prilozi Pub Date : 2022-03-01 DOI: 10.2478/prilozi-2022-0010

B. Korucu, Hasan Yeter, Galip Guz

{"title":"The Effects of CNI and Mtori-Based Regimens on Bone Mineral Density After Renal Transplantation","authors":"B. Korucu, Hasan Yeter, Galip Guz","doi":"10.2478/prilozi-2022-0010","DOIUrl":"https://doi.org/10.2478/prilozi-2022-0010","url":null,"abstract":"Abstract Background: Since glucocorticoids are used in low maintenance doses today, the relationship between calcineurin inhibitors (CNI) and osteoporosis has become clinically significant in osteoporosis after solid organ transplantation. However, there is evidence that the mammalian target of rapamycin inhibitors (mTORi) may be beneficial via osteoclast inhibition. Objective: The bone mineral density (BMD) changes are investigated in renal transplant patients under CNI or mTORi-based maintenance regimens during the first five-year post-transplant course. Methods: This study consists of thirty-three renal allograft recipients with less than one year of dialysis history. The exclusion criteria were: being older than 50 years old, history of bisphosphonate use, parathyroidectomy, CNI-mTORi switch after the post-transplant third month, diuretic use, and history of malignancy. First and fifth-year BMD scores and simultaneous laboratory parameters were evaluated. Results: CNI (n=21) and mTORi group (n=12) had similar demographics, dialysis vintages, first and fifth-year serum parathormone, calcium, phosphate, magnesium, alkaline phosphatase, and 25-OH-vitamin D levels. The femur neck scores of the CNI group decreased from -0.82 (±0.96) to -1.52 (±0.92) (p=0.020). We observed a significant decrease in the CNI group compared to the mTORi group [-0.70 (±0.68) and 0.30 (±0.36), respectively; p<0.01] when the BMD score changes were evaluated among years. The mean femur neck score of the mTORi group increased insignificantly from -1.13 (±0.65) to -0.82 (±0.56) at the fifth-year DXA scan (p=0.230). Similar trends were also observed in L1-4 scores. Conclusion: Our study suggests that CNI-based treatment is associated with decreased femur neck BMD scores, and mTORi-based treatment tends to be beneficial in the post-transplant five-year follow-up.","PeriodicalId":87202,"journal":{"name":"Prilozi","volume":"3 1","pages":"101 - 107"},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82903858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0